Octatropine methylbromide

Octatropine methylbromide (also known as Anaspaz, Levsin, and Hyosyne) is a pharmacological agent that acts as an anticholinergic and antispasmodic. It is used in the treatment of various gastrointestinal disorders such as irritable bowel syndrome and peptic ulcer disease.

Pharmacology

Octatropine methylbromide is a quaternary ammonium compound that exerts its effects by blocking the action of acetylcholine at muscarinic receptors. This results in a decrease in the activity of the parasympathetic nervous system, leading to a reduction in smooth muscle contractions and secretions in the gastrointestinal tract.

Clinical Use

Octatropine methylbromide is used in the management of various gastrointestinal disorders. It is particularly effective in the treatment of irritable bowel syndrome and peptic ulcer disease, where it helps to reduce the frequency and severity of spasms and pain. It may also be used in the treatment of other conditions where a reduction in gastrointestinal motility and secretions is beneficial.

Side Effects

As with all medications, octatropine methylbromide can cause side effects. These may include dry mouth, blurred vision, constipation, and urinary retention. In rare cases, it may cause serious side effects such as confusion, hallucinations, and tachycardia. Patients should be monitored closely for these side effects and the medication should be discontinued if they occur.

Contraindications

Octatropine methylbromide is contraindicated in patients with glaucoma, myasthenia gravis, and prostatic hypertrophy. It should also be used with caution in patients with cardiac disease due to the risk of tachycardia.

See Also

• Anticholinergic
• Antispasmodic
• Irritable bowel syndrome
• Peptic ulcer disease

Octatropine methylbromide Resources
Latest articles Most recent articles Ongoing trials	Wikipedia